Extramedullary Plasmacytoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2026-04-20
Clinical Trial Update: Daratumumab Combined With Bortezomib, Cyclophosphamide and Dexamethasone for the Treatment of Multiple Myeloma Patients Presenting With Extramedullary Disease [Phase 2]
This update describes a Phase 2 trial evaluating a four-drug regimen (daratumumab, bortezomib, cyclophosphamide, and dexamethasone) for mult…